{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:17:36Z","timestamp":1789777056864,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 20K16009"],"award-info":[{"award-number":["JP 20K16009"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K22494"],"award-info":[{"award-number":["JP19K22494"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H00491"],"award-info":[{"award-number":["JP20H00491"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.neuropharm.2021.108926","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T01:40:59Z","timestamp":1639618859000},"page":"108926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A selective serotonin reuptake inhibitor ameliorates obsessive\u2013compulsive disorder-like perseverative behavior by attenuating 5-HT2C receptor signaling in the orbitofrontal cortex"],"prefix":"10.1016","volume":"206","author":[{"given":"Hikari","family":"Hatakama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7438-732X","authenticated-orcid":false,"given":"Kazuki","family":"Nagayasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4129-0978","authenticated-orcid":false,"given":"Hisashi","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5152-5809","authenticated-orcid":false,"given":"Shuji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.neuropharm.2021.108926_bib1","article-title":"Optogenetically-induced long term depression in the rat orbitofrontal cortex ameliorates stress-induced reversal learning impairment","volume":"24","author":"Adler","year":"2020","journal-title":"Neurobiol. Stress."},{"issue":"20","key":"10.1016\/j.neuropharm.2021.108926_bib2","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1523\/JNEUROSCI.0011-12.2012","article-title":"Laminarly orthogonal excitation of fast-spiking and low-threshold-spiking interneurons in mouse motor cortex","volume":"16;32","author":"Apicella","year":"2012","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108926_bib3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/BF00167182","article-title":"The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram","volume":"353","author":"Arborelius","year":"1996","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2021.108926_bib4","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.2121-20.2021","article-title":"NOX1\/NADPH oxidase promotes synaptic facilitation induced by repeated D2 receptor stimulation: involvement in behavioral repetition","volume":"24;41","author":"Asaoka","year":"2021","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108926_bib56","doi-asserted-by":"crossref","first-page":"13609","DOI":"10.1038\/s41598-017-13599-3","article-title":"Chronic antidepressant potentiates spontaneous activity of dorsal raphe serotonergic neurons by decreasing GABAB receptor-mediated inhibition of L-type calcium channelsAsaoka N","volume":"7","author":"Asaoka","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108926_bib5","first-page":"6","article-title":"An adenosine A2A receptor antagonist improves multiple symptoms of repeated quinpirole-induced psychosis","volume":"27","author":"Asaoka","year":"2019","journal-title":"eNeuro"},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108926_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archpsyc.1987.01800150017003","article-title":"Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls","volume":"44","author":"Baxter","year":"1987","journal-title":"Arch. Gen. Psychiatr."},{"issue":"7824","key":"10.1016\/j.neuropharm.2021.108926_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41586-020-2704-z","article-title":"Value-guided remapping of sensory cortex by lateral orbitofrontal cortex","volume":"585","author":"Banerjee","year":"2020","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108926_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.neuint.2011.07.013","article-title":"Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels","volume":"59","author":"Barbon","year":"2011","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108926_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archpsyc.1994.03950040053007","article-title":"Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors","volume":"51","author":"Barr","year":"1994","journal-title":"Arch. Gen. Psychiatr."},{"issue":"23","key":"10.1016\/j.neuropharm.2021.108926_bib9","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1523\/JNEUROSCI.19-23-10494.1999","article-title":"Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level","volume":"1;19","author":"Benmansour","year":"1999","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108926_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s002130050923","article-title":"Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study","volume":"143","author":"Bergqvist","year":"1999","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108926_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.biopsych.2005.08.023","article-title":"Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients","volume":"1;59","author":"Berney","year":"2006","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108926_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamapsychiatry.2013.173","article-title":"Abnormally high degree connectivity of the orbitofrontal cortex in obsessive-compulsive disorder","volume":"70","author":"Beucke","year":"2013","journal-title":"JAMA Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2021.108926_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biopsych.2014.07.023","article-title":"Interneurons are necessary for coordinated activity during reversal learning in orbitofrontal cortex","volume":"1;77","author":"Bissonette","year":"2015","journal-title":"Biol. Psychiatr."},{"issue":"8","key":"10.1016\/j.neuropharm.2021.108926_bib14","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1301584","article-title":"Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats","volume":"33","author":"Boulougouris","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108926_bib15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1523\/JNEUROSCI.4312-09.2010","article-title":"Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific","volume":"20;30","author":"Boulougouris","year":"2010","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2021.108926_bib16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/j.1460-9568.2009.06992.x","article-title":"Orbitofrontal inactivation impairs reversal of Pavlovian learning by interfering with 'disinhibition' of responding for previously unrewarded cues","volume":"30","author":"Burke","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"15","key":"10.1016\/j.neuropharm.2021.108926_bib17","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1523\/JNEUROSCI.0067-04.2004","article-title":"Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability","volume":"24","author":"Carta","year":"2004","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108926_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/jpn.0427","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"Journal of psychiatry & neuroscience: JPN"},{"issue":"7481","key":"10.1016\/j.neuropharm.2021.108926_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature12755","article-title":"Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression","volume":"2","author":"Courtin","year":"2014","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108926_bib20","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1523\/JNEUROSCI.3366-15.2016","article-title":"Multifaceted contributions by different regions of the orbitofrontal and medial prefrontal cortex to probabilistic reversal learning","volume":"10;36","author":"Dalton","year":"2016","journal-title":"J. Neurosci."},{"issue":"6569","key":"10.1016\/j.neuropharm.2021.108926_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/380069a0","article-title":"Dissociation in prefrontal cortex of affective and attentional shifts","volume":"7;380","author":"Dias","year":"1996","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108926_bib22","doi-asserted-by":"crossref","first-page":"pyv047","DOI":"10.1093\/ijnp\/pyv047","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"4;18","author":"Dold","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108926_bib23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1139\/jpn.0536","article-title":"Responsiveness of 5-HT1A and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition","volume":"30","author":"El Mansari","year":"2005","journal-title":"J. Psychiatr. Neurosci.: JPN"},{"key":"10.1016\/j.neuropharm.2021.108926_bib24","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2007"},{"issue":"7","key":"10.1016\/j.neuropharm.2021.108926_bib25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1176\/appi.ajp.2011.10071062","article-title":"Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder","volume":"68","author":"Gillan","year":"2011","journal-title":"Am. J. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108926_bib26","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.celrep.2018.11.010","article-title":"Early Life stress drives sex-selective impairment in reversal learning by affecting parvalbumin interneurons in orbitofrontal cortex of mice","volume":"27;25","author":"Goodwill","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108926_bib27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neuron.2019.05.042","article-title":"Orbitofrontal circuits control multiple reinforcement-learning processes","volume":"21;103","author":"Groman","year":"2019","journal-title":"Neuron"},{"issue":"46","key":"10.1016\/j.neuropharm.2021.108926_bib28","doi-asserted-by":"crossref","first-page":"18041","DOI":"10.1073\/pnas.0806669105","article-title":"Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs","volume":"18;105","author":"Homayoun","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2021.108926_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(94)90344-1","article-title":"Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors","volume":"1;260","author":"Invernizzi","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108926_bib30","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1523\/JNEUROSCI.4942-12.2013","article-title":"Basolateral amygdala lesions facilitate reward choices after negative feedback in rats","volume":"27;33","author":"Izquierdo","year":"2013","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108926_bib31","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1038\/tp.2014.68","article-title":"Genetic neuropathology of obsessive psychiatric syndromes","volume":"2;4","author":"Jaffe","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"7483","key":"10.1016\/j.neuropharm.2021.108926_bib32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature12983","article-title":"Interneuron cell types are fit to function","volume":"16;505","author":"Kepecs","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108926_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00210-004-0951-4","article-title":"Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors","volume":"370","author":"Knight","year":"2004","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2021.108926_bib34","article-title":"GluA4 facilitates cerebellar expansion coding and enables associative memory formation","volume":"5","author":"Kita","year":"2021","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108926_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrn1747","article-title":"The human orbitofrontal cortex: linking reward to hedonic experience","volume":"6","author":"Kringelbach","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2021.108926_bib36","first-page":"127","article-title":"Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: preliminary results","volume":"56","author":"K\u00fclz","year":"2008","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108926_bib37","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.neuroscience.2007.02.064","article-title":"Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction","volume":"8;146","author":"Liu","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108926_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02805977","article-title":"The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain","volume":"27","author":"Maj","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108926_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.ajp.158.1.78","article-title":"The effect of paroxetine on 5-HT2A receptors in depression: an [(18)F] setoperone PET imaging study","volume":"158","author":"Meyer","year":"2001","journal-title":"Am. J. Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2021.108926_bib40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108926_bib41","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1038\/tp.2014.62","article-title":"Repetitive transcranial magnetic stimulation over the orbitofrontal cortex for obsessive-compulsive disorder: a double-blind, crossover study","volume":"4","author":"Nauczyciel","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2021.108926_bib42","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1017\/S0033291709005297","article-title":"Patients with obsessive-compulsive disorder are impaired in associative learning based on external feedback","volume":"39","author":"Nielen","year":"2009","journal-title":"Psychol. Med."},{"issue":"297","key":"10.1016\/j.neuropharm.2021.108926_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2015.03.050","article-title":"Serotonin-2C and -2A receptor co-expression on cells in the rat medial prefrontal cortex","volume":"25","author":"Nocjar","year":"2015","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.neuropharm.2021.108926_bib44","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/mp.2013.144","article-title":"Serotonin 2C receptor antagonists induce fast-onset antidepressant effects","volume":"19","author":"Opal","year":"2014","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108926_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108926_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bjp.0702751","article-title":"Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells","volume":"128","author":"Porter","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108926_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/dneu.20853","article-title":"Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons","volume":"1;71","author":"Rudy","year":"2011","journal-title":"Dev Neurobiol."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108926_bib50","first-page":"3125","article-title":"Expression of Serotonin2C receptors in pyramidal and GABAergic neurons of rat prefrontal cortex: a comparison with striatum","volume":"1;27","author":"Santana","year":"2017","journal-title":"Cerebr. Cortex"},{"issue":"10","key":"10.1016\/j.neuropharm.2021.108926_bib51","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cerebr. Cortex"},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108926_bib52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0893-133X(99)00082-2","article-title":"Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder","volume":"21","author":"Saxena","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108926_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnins.2018.00345","article-title":"Insulin regulates GABAA receptor-mediated tonic currents in the prefrontal cortex","volume":"12","author":"Trujeque-Ramos","year":"2018","journal-title":"Front. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2021.108926_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.165","article-title":"Motivation and value influences in the relative balance of goal-directed and habitual behaviours in obsessive-compulsive disorder","volume":"3;5","author":"Voon","year":"2015","journal-title":"Transl. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821004834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821004834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:15:24Z","timestamp":1758438924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821004834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":54,"alternative-id":["S0028390821004834"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108926","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A selective serotonin reuptake inhibitor ameliorates obsessive\u2013compulsive disorder-like perseverative behavior by attenuating 5-HT2C receptor signaling in the orbitofrontal cortex","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108926"}}